Articles with public access mandates - Mohamed SorrorLearn more
Not available anywhere: 7
Cytomegalovirus viral load and mortality after haemopoietic stem cell transplantation in the era of pre-emptive therapy: a retrospective cohort study
ML Green, W Leisenring, HU Xie, TC Mast, Y Cui, BM Sandmaier, ...
The Lancet Haematology 3 (3), e119-e127, 2016
Mandates: US National Institutes of Health
Intensified postgrafting immunosuppression failed to assure long-term engraftment of dog leukocyte antigen-identical canine marrow grafts after 1 gray total body irradiation
ML Sorror, W Leisenring, M Mielcarek, F Baron, R Diaconescu, WJ Hogan, ...
Transplantation 85 (7), 1023-1029, 2008
Mandates: US National Institutes of Health
Comorbidities, age, and other patient-related predictors of allogeneic hematopoietic cell transplantation outcomes
V Wais, D Bunjes, F Kuchenbauer, ML Sorror
Expert Review of Hematology 11 (10), 805-816, 2018
Mandates: US National Institutes of Health
Hematopoietic cell transplantation comorbidity index and risk of developing invasive fungal infections after allografting
A Busca, R Passera, E Maffini, M Festuccia, L Brunello, CM Dellacasa, ...
Bone Marrow Transplantation 53 (10), 1304-1310, 2018
Mandates: US National Institutes of Health, Fondazione Cariplo, Government of Italy
Assignment of scores for the hematopoietic cell transplantation comorbidity index: integer vs exact weights
ML Sorror, B Storer, R Storb
Bone marrow transplantation 46 (3), 464-466, 2011
Mandates: US National Institutes of Health
Incorporating physical function and cognition into mortality risk assessment for acute myeloid leukemia—reply
ML Sorror, BE Storer, EH Estey
JAMA oncology 4 (7), 1014-1015, 2018
Mandates: Patient-Centered Outcomes Research Institute
Risk‐benefit assessment in allogeneic hematopoietic transplant: Factors, scores, and models
M Elsawy, ML Sorror
Clinical Manual of Blood and Bone Marrow Transplantation, 19-35, 2017
Mandates: National Institute for Health Research, UK
Available somewhere: 106
Reduced mortality after allogeneic hematopoietic-cell transplantation
TA Gooley, JW Chien, SA Pergam, S Hingorani, ML Sorror, M Boeckh, ...
New England Journal of Medicine 363 (22), 2091-2101, 2010
Mandates: US National Institutes of Health
Long-term survival and late deaths after allogeneic hematopoietic cell transplantation
JR Wingard, NS Majhail, R Brazauskas, Z Wang, KA Sobocinski, ...
Journal of clinical oncology 29 (16), 2230-2239, 2011
Mandates: US National Institutes of Health
Comorbidity-age index: a clinical measure of biologic age before allogeneic hematopoietic cell transplantation
ML Sorror, RF Storb, BM Sandmaier, RT Maziarz, MA Pulsipher, MB Maris, ...
Journal of Clinical Oncology 32 (29), 3249-3256, 2014
Mandates: US National Institutes of Health
Impact of pretransplantation minimal residual disease, as detected by multiparametric flow cytometry, on outcome of myeloablative hematopoietic cell transplantation for acute …
RB Walter, TA Gooley, BL Wood, F Milano, M Fang, ML Sorror, EH Estey, ...
Journal of clinical oncology 29 (9), 1190-1197, 2011
Mandates: US National Institutes of Health
Cord-blood transplantation in patients with minimal residual disease
F Milano, T Gooley, B Wood, A Woolfrey, ME Flowers, K Doney, ...
New England Journal of Medicine 375 (10), 944-953, 2016
Mandates: US National Institutes of Health
A disease risk index for patients undergoing allogeneic stem cell transplantation
P Armand, CJ Gibson, C Cutler, VT Ho, J Koreth, EP Alyea, J Ritz, ...
Blood, The Journal of the American Society of Hematology 120 (4), 905-913, 2012
Mandates: US National Institutes of Health
Five-year follow-up of patients with advanced chronic lymphocytic leukemia treated with allogeneic hematopoietic cell transplantation after nonmyeloablative conditioning
ML Sorror, BE Storer, BM Sandmaier, M Maris, J Shizuru, R Maziarz, ...
Journal of Clinical Oncology 26 (30), 4912-4920, 2008
Mandates: US National Institutes of Health
Long-term outcomes among older patients following nonmyeloablative conditioning and allogeneic hematopoietic cell transplantation for advanced hematologic malignancies
ML Sorror, BM Sandmaier, BE Storer, GN Franke, GG Laport, ...
Jama 306 (17), 1874-1883, 2011
Mandates: US National Institutes of Health
Hematopoietic cell transplantation‐comorbidity index and Karnofsky performance status are independent predictors of morbidity and mortality after allogeneic nonmyeloablative …
M Sorror, B Storer, BM Sandmaier, DG Maloney, TR Chauncey, ...
Cancer 112 (9), 1992-2001, 2008
Mandates: US National Institutes of Health
Late events after treatment with CD19-targeted chimeric antigen receptor modified T cells
A Cordeiro, ED Bezerra, AV Hirayama, JA Hill, QV Wu, J Voutsinas, ...
Biology of Blood and Marrow Transplantation 26 (1), 26-33, 2020
Mandates: US National Institutes of Health
Graft-versus-host disease and graft-versus-tumor effects after allogeneic hematopoietic cell transplantation
R Storb, B Gyurkocza, BE Storer, ML Sorror, K Blume, D Niederwieser, ...
Journal of Clinical Oncology 31 (12), 1530-1538, 2013
Mandates: US National Institutes of Health
Increasing use of allogeneic hematopoietic cell transplantation in patients aged 70 years and older in the United States
L Muffly, MC Pasquini, M Martens, R Brazauskas, X Zhu, K Adekola, ...
Blood, The Journal of the American Society of Hematology 130 (9), 1156-1164, 2017
Mandates: US Department of Defense, US National Institutes of Health, Patient-Centered …
Comparison of minimal residual disease as outcome predictor for AML patients in first complete remission undergoing myeloablative or nonmyeloablative allogeneic hematopoietic …
RB Walter, B Gyurkocza, BE Storer, CD Godwin, JM Pagel, SA Buckley, ...
Leukemia 29 (1), 137-144, 2015
Mandates: US National Institutes of Health
Publication and funding information is determined automatically by a computer program